Literature DB >> 30551896

HIF-1α inducing exosomal microRNA-23a expression mediates the cross-talk between tubular epithelial cells and macrophages in tubulointerstitial inflammation.

Zuo-Lin Li1, Lin-Li Lv2, Tao-Tao Tang1, Bin Wang1, Ye Feng1, Le-Ting Zhou1, Jing-Yuan Cao1, Ri-Ning Tang1, Min Wu1, Hong Liu1, Steven D Crowley3, Bi-Cheng Liu4.   

Abstract

Hypoxia promotes tubulointerstitial inflammation in the kidney. Although hypoxia inducible factor-1α (HIF-1α) is a master regulator of the response to hypoxia, the exact mechanisms through which HIF-1α modulates the induction of tubulointerstitial inflammation are still largely unclear. We demonstrated tubulointerstitial inflammation and increased tubular HIF-1α expression in murine models of ischemia/reperfusion injury and unilateral ureteral obstruction. Increased expression of HIF-1α in tubular epithelial cells was associated with selective shedding of microRNA-23a (miRNA-23a)-enriched exosomes in vivo and systemic inhibition of miRNA-23a prior to ischemia/reperfusion injury attenuated tubulointerstitial inflammation. In vitro, uptake of miRNA-23a-enriched exosomes by macrophages triggered their reprogramming into a pro-inflammatory state via suppression of the ubiquitin editor A20. To confirm the effect of miRNA-23a-containing exosomes on tubulointerstitial inflammation, we exposed tubular epithelial cells to hypoxic conditions to promote the release of miRNA-23a-containing exosomes. Injection of these miRNA-23a-enriched exosomes into uninjured renal parenchyma resulted in increased inflammatory infiltration in vivo. Taken together, our studies demonstrate that the HIF-1α-dependent release of miRNA-23a-enriched exosomes from hypoxic tubular epithelial cells activates macrophages to promote tubulointerstitial inflammation. Blockade of exosome-mediated miRNA-23a transfer between tubular epithelial cells and macrophages may serve as a novel therapeutic approach to ameliorate tubulointerstitial inflammation.
Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  exosome; hypoxia inducible factor-1α (HIF-1α); macrophages; microRNA-23a; tubular epithelial cells; tubulointerstitial inflammation

Year:  2018        PMID: 30551896     DOI: 10.1016/j.kint.2018.09.013

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  58 in total

Review 1.  The regulatory role of HIF-1 in tubular epithelial cells in response to kidney injury.

Authors:  Yumei Qiu; Xiaowen Huang; Weichun He
Journal:  Histol Histopathol       Date:  2019-11-06       Impact factor: 2.303

Review 2.  The crosstalk between hypoxia-inducible factor-1α and microRNAs in acute kidney injury.

Authors:  Zhiyu Wang; Wen Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-29

Review 3.  Preconditioning against renal ischaemia reperfusion injury: the failure to translate to the clinic.

Authors:  Dermot O'Kane; Graham S Baldwin; Damien M Bolton; Joseph J Ischia; Oneel Patel
Journal:  J Nephrol       Date:  2019-01-11       Impact factor: 3.902

4.  The profibrotic effects of MK-8617 on tubulointerstitial fibrosis mediated by the KLF5 regulating pathway.

Authors:  Zuo-Lin Li; Lin-Li Lv; Bin Wang; Tao-Tao Tang; Ye Feng; Jing-Yuan Cao; Li-Qiong Jiang; Yan-Bei Sun; Hong Liu; Xiao-Liang Zhang; Kun-Ling Ma; Ri-Ning Tang; Bi-Cheng Liu
Journal:  FASEB J       Date:  2019-08-26       Impact factor: 5.191

Review 5.  Renoprotective Role of Hypoxia-Inducible Factors and the Mechanism.

Authors:  Qiu-Yu Li; Fei Liu; Xiaoxiao Tang; Haidong Fu; Jianhua Mao
Journal:  Kidney Dis (Basel)       Date:  2021-11-23

Review 6.  Treatment of Renal Anemia with Roxadustat: Advantages and Achievement.

Authors:  Zuo-Lin Li; Yan Tu; Bi-Cheng Liu
Journal:  Kidney Dis (Basel)       Date:  2020-01-10

7.  Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against renal ischemia/reperfusion injury by inhibiting inflammation.

Authors:  A-Feng Miao; Jian-Xiang Liang; Lei Yao; Jun-Ling Han; Li-Juan Zhou
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

8.  Extracellular vesicles in kidneys and their clinical potential in renal diseases.

Authors:  Sul A Lee; Chulhee Choi; Tae-Hyun Yoo
Journal:  Kidney Res Clin Pract       Date:  2021-04-13

Review 9.  Macrophage Heterogeneity in Kidney Injury and Fibrosis.

Authors:  Yi Wen; Hong-Ru Yan; Bin Wang; Bi-Cheng Liu
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

Review 10.  Extracellular vesicle activities regulating macrophage- and tissue-mediated injury and repair responses.

Authors:  Qian Hu; Christopher J Lyon; Jesse K Fletcher; Wenfu Tang; Meihua Wan; Tony Y Hu
Journal:  Acta Pharm Sin B       Date:  2020-12-19       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.